In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack

Autors: BNS
Datums: 05.11.2007
Izdevums: BNS
Rubrika: Citas ziņas